ArticleCell death and differentiation2026
E3 ubiquitin ligase Stub1 enhances viral replication by promoting TBK1 degradation through molecular chaperone-mediated autophagy.
Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
As a crucial kinase in the host antiviral innate immune signaling pathway, TANK-binding kinase 1 (TBK1) is strictly regulated by various posttranslational modifications. Previous studies have demonstrated that the stability of TBK1 can be compromised through autophagy; however, the precise mechanisms involved in the regulation of TBK1 degradation remain unclear. In this study, we revealed that the E3 ubiquitin ligase Stub1 can inhibit the production of type I interferon (IFN-I) by targeting TBK1, thereby preventing host antiviral responses. Mechanistically, TBK1 is targeted for degradation by chaperone-mediated autophagy (CMA), which depends on its three typical motifs. This process relies on the interaction between TBK1 and Stub1. Simultaneously, Stub1 catalyzes the polyubiquitination of TBK1 at lysine 344 (K344), which is linked to K27. The ubiquitinated TBK1 is recognized by heat shock cognate protein 70 (HSC70/HspA8), resulting in autophagic degradation via CMA mediated by LAMP2A. Compared with wild-type mice, Stub1-deficient mice exhibit increased resistance to VSV and HSV-1 infection, accompanied by increased expression levels of type I IFN. Overall, our findings reveal a TBK1-Stub1 axis in the RIG-I and cGAS-STING pathways, highlighting the effects of CMA on host antiviral innate immune responses.
Identifiers
41882146What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.